2008-10-16 22:58:01 -

www.windhover.com/in3east08 - Medtech Insight/Windhover Information, an Elsevier company Kristy Grimes, 480-985-9512 or 888-202-5939 toll-free in the U.S. kristy@medtechinsight.com www.medtechinsight.com Medtech Insight/Windhover Information, an Elsevier company, and a leading provider of business information for the medical device industry, has announced that 65+ early- to late-stage companies are now confirmed to present at their upcoming "Investment In Innovation (In3) East" conference, being held next week -- October 22-24, 2008 at The Westin Copley Place in Boston, MA. Presentation timeslots are now filled and a growing number of start-up companies are waitlisted for this popular event, designed for those looking to partner, invest and network with the most promising start-up medical technology companies on course to impact the worldwide med device market. Preceding

In3 East will be a first-of-its-kind "Medical Device Investor Day" symposium, featuring illuminating presentations by the most influential large companies in the device space. More than 500 attendees are registered to attend these events to date.

Presenters at the two-day, single-track In3 East event - the company's 32nd In3 conference - are seeking to raise funding or form strategic partnerships. Presenting companies (the majority presenting at an In3 event for the first time) from the U.S., Canada, Europe and Israel include ACell, Inc., Advanced BioSensors, Inc., AugmentRx Medical, Inc., Axogen, Inc., BrainScope Company, Inc., Cardiola, Ltd., CardioMag Imaging, Inc., Ceragenix Pharmaceuticals, Cerapedics, Inc., Cohera Medical, Inc., Core Essence Orthopaedics Inc., CoreSpine Technologies, Curative Biosciences, Inc., CVAC Systems, Inc., Delcath Systems, Inc., DermTech International, Diopsys, Discovery Technology International, LLP, eCardio Diagnostics, Endosense SA, EndoSphere Inc., Envisionier Medical Technologies, EyeMarker Systems, Inc., FAST Diagnostics, Genesis Medical Interventional, Inc., Healionics Corporation, HydroCision, Inc., Infoscitex Corporation, Inovio Biomedical Corporation, Inset Inc., InspireMD, Intellwave, LLC, LifeBond Ltd., LineaGen, Inc., L.R.S. Ortho, MicroTransponder Inc., Minnow Medical, mNemoscience GmbH, MTM Laboratories, nContact Surgical, Inc., NeoMend, Inc., Nerites Corporation, Osprey Medical Inc., PEAK Surgical, Inc., Polymedix, Inc., Respirion, Inc., Rosetta Genomics, Sage Technology & Development, Science Applications International Corporation, Scil Technology GmbH, Sensimed AG, Sentinel Group LLC, Sherlock-NMD, SMT R&D, SonoMedix, Spinal Elements, Symbios Medical, TissueGen, Inc., Urovalve, Inc., Victhom Human Bionics Inc., ViOptix Inc., Vista LifeSciences, Vivostat A/S, and Xylos Corporation. Companies with tabletop exhibits and reserved luncheon tables on October 23rd that are on the waiting list for a presentation timeslot include HemoSonics, Lerner Medical Devices, POEMS Ltd., and Sensile Medical AG, with more being added to the list regularly.

The program will also feature a pre-conference panel on Oct. 22 hosted by Christopher Velis, Chairman and CEO of Medical Capital Advisors, entitled "Top Strategies: Global Update U.S., India, China - Getting Finance in a Bad Economic Environment." An informative keynote panel discussion will take place on Oct. 23, entitled "Stories Behind How Financing Deals Got Done," with panelists to include David Milne, Managing Partner, SV Life Science Advisers LP; Kevin Connors, General Partner, Spray Venture Partners; and Amir Nashat, General Partner, Polaris Ventures. A presenting company product exhibition and networking reception will take place on Thursday evening. A third interactive panel, "FDA Update: Tips for Smooth and Successful Interactions with CDRH," will be held on Oct. 24. Christy Foreman, Acting Deputy Director for Science and Review Policy, FDA Office of Device Evaluation, and Laurie A. Clarke, Partner, King & Spalding are confirmed to participate on this panel.

In3 East co-sponsors include AdvaMed, Averion, Battelle, Business Wire, Edwards Angell Palmer & Dodge, Invest In Germany, MDMA, Medmarc and The Hartford, Medical Capital Advisors, Push-Med, The MedTech Group, Ronald Trahan Associates, TATRC, and FDC Reports' "The Gray Sheet." Visit www.windhover.com/in3east08 for regularly updated program details, and to download the new event brochure.

The Medical Device Investor Day Symposium, being held on Oct. 22, is a first-of-its-kind event that will showcase illuminating presentations by approximately 12 of the most influential large companies in the device space. Senior executives from each of these hand-selected companies will speak candidly on what interests them most in medical device technologies, therapeutic areas, products, and geographic markets. They will also inform our audience about partnering opportunities, how companies can maximize their visibility in front of large company investors, and what role M&A plays at their companies. The 11 confirmed presenters for Investor Day to date include: Susan Paquette, Technology Assessment Director, 3M; Paul O'Connell, Vice President, Vascular Interventional Products Group, B. Braun Medical; Albert Lauritano, Director, Business Development, Becton Dickinson (BD); Jim Gilbert, Executive Vice President, Strategy and Business Development, Boston Scientific Corporation; Dennis Crowley, Vice President of Corporate Development, Covidien; Bob Mellen, VP, Strategic Planning & Business Development, C.R. Bard; Margaret Helms, Director, WW New Business Development, Ethicon/J&J Shawn McCormick, Vice President, Medtronic Business Development; Anupendra Sharma, Investment Partner, Siemens Venture Capital, Inc.; Matt Alves, VP, Strategic Development, Stryker Corporation; and Ted Davis, Vice President, Business Development, Wright Medical Technology.

Investor Day will be kicked off with an interactive keynote panel discussion entitled "Larger Medical Technology Company M&A/Deal Trends." David Cassak, Managing Partner, and Stephen Levin, Executive Editor, Windhover Information will be the moderators, and panelists will include Albert A. Lauritano, MSc, CLP, Director of Business Development at BD Technologies; Paul O'Connell, President of B. Braun Vascular Systems; Dennis Crowley, Vice President of Corporate Development at Covidien; and Jim Gilbert, Executive Vice President, Strategy and Business Development, Boston Scientific Corporation. The event will conclude with a Special Closing Address by Mark Leahey, Executive Director, Medical Device Manufacturers Association, entitled "The Impact of the Fall Presidential Elections on the Device Industry." Investor Day is a must-attend event for those interested in what the leaders of the med device industry are thinking, doing, and planning in terms of investment. Visit www.windhover.com/investorday for more information, and to download the event brochure.

Medtech Insight/Windhover Information and its parent company, Elsevier, have established a reputation as holding the premier forums worldwide for discerning senior executives in the medical device, diagnostics, biotech, and pharmaceutical business development and investment communities to meet and screen promising early-stage life sciences companies in need of funding, acquisition and/or strategic partnership, and to network with key decision makers in the industry. Over 1400 emerging medical technology company presenters and over 7500 attendees have participated at In3 events over the past 7 years.

Upcoming medtech investment and partnering events from Medtech Insight/Windhover include their "Investment In Innovation (In3) West" conference at The Palazzo in Las Vegas, NV, March 2-4, 2009, followed by "Investment In Innovation (In3) Europe" at the Marriott Rive Gauche Hotel in Paris, April 29-30.

More than 500 Attendees Registered to Date